Selected research
Market Structure
Global Genetically Modified Animal Models Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Genetically Modified Animal Models market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Genetically Modified Animal Models include ModelOrg, GemPharmatech, Cyagen Biosciences, Biocytogen, JOINN, China Environmental Technology and Bioenergy, Charles River, Taconic Biosciences and GenOway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Genetically Modified Animal Models market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Genetically Modified Animal Models and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Genetically Modified Animal Models revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Genetically Modified Animal Models market size, projected growth trends, production technologies, key applications, and end-use industries.
Genetically Modified Animal Models Segment by Company
ModelOrg
GemPharmatech
Cyagen Biosciences
Biocytogen
JOINN
China Environmental Technology and Bioenergy
Charles River
Taconic Biosciences
GenOway
CLEA Japan
Ozgene
InVivo Biosystems
Harbour BioMed
PolyGene
Genetically Modified Animal Models Segment by Type
Rodents
Non-Human Primates
Zebrafish
Others
Genetically Modified Animal Models Segment by Application
Universities
Hospitals
Pharmaceutical Companies
Others
Genetically Modified Animal Models Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Animal Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Animal Models and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Animal Models.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Genetically Modified Animal Models in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genetically Modified Animal Models industry.
Chapter 3: Detailed analysis of Genetically Modified Animal Models companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetically Modified Animal Modelsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rodents
- Non-Human Primates
- Zebrafish
- Others
Applications
- Universities
- Hospitals
- Pharmaceutical Companies
- Others
Companies covered
- ModelOrg
- GemPharmatech
- Cyagen Biosciences
- Biocytogen
- JOINN
- China Environmental Technology and Bioenergy
- Charles River
- Taconic Biosciences
- GenOway
- CLEA Japan
- Ozgene
- InVivo Biosystems
- Harbour BioMed
- PolyGene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Genetically Modified Animal Models Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Rodents
- 1.2.3 Non-Human Primates
- 1.2.4 Zebrafish
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Genetically Modified Animal Models Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Universities
- 1.3.3 Hospitals
- 1.3.4 Pharmaceutical Companies
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Genetically Modified Animal Models Growth Trends by Region
- 1.5.1 Global Genetically Modified Animal Models Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Genetically Modified Animal Models Market Size by Region (2021-2026)
- 1.5.3 Genetically Modified Animal Models Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Genetically Modified Animal Models Market Dynamics
- 2.1 Genetically Modified Animal Models Industry Trends
- 2.2 Genetically Modified Animal Models Industry Drivers
- 2.3 Genetically Modified Animal Models Industry Opportunities and Challenges
- 2.4 Genetically Modified Animal Models Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Genetically Modified Animal Models Revenue by Company (2021-2026)
- 3.2 Global Genetically Modified Animal Models Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Genetically Modified Animal Models Key Company Head office and Area Served
- 3.4 Global Genetically Modified Animal Models Company, Product Type & Application
- 3.5 Global Genetically Modified Animal Models Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Genetically Modified Animal Models Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Genetically Modified Animal Models Players Market Share by Revenue in 2025
- 3.6.3 2025 Genetically Modified Animal Models Tier 1, Tier 2, and Tier 3
4 Genetically Modified Animal Models Market by Type
- 4.1 Global Genetically Modified Animal Models Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Genetically Modified Animal Models Market Size by Type (2021-2032)
- 4.3 Global Genetically Modified Animal Models Market Size Share by Type (2021-2032)
5 Genetically Modified Animal Models Market by Application
- 5.1 Global Genetically Modified Animal Models Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Genetically Modified Animal Models Market Size by Application (2021-2032)
- 5.3 Global Genetically Modified Animal Models Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 ModelOrg
- 6.1.1 ModelOrg Company Information
- 6.1.2 ModelOrg Business Overview
- 6.1.3 ModelOrg Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 ModelOrg Genetically Modified Animal Models Product Portfolio
- 6.1.5 ModelOrg Recent Developments
- 6.2 GemPharmatech
- 6.2.1 GemPharmatech Company Information
- 6.2.2 GemPharmatech Business Overview
- 6.2.3 GemPharmatech Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GemPharmatech Genetically Modified Animal Models Product Portfolio
- 6.2.5 GemPharmatech Recent Developments
- 6.3 Cyagen Biosciences
- 6.3.1 Cyagen Biosciences Company Information
- 6.3.2 Cyagen Biosciences Business Overview
- 6.3.3 Cyagen Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cyagen Biosciences Genetically Modified Animal Models Product Portfolio
- 6.3.5 Cyagen Biosciences Recent Developments
- 6.4 Biocytogen
- 6.4.1 Biocytogen Company Information
- 6.4.2 Biocytogen Business Overview
- 6.4.3 Biocytogen Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Biocytogen Genetically Modified Animal Models Product Portfolio
- 6.4.5 Biocytogen Recent Developments
- 6.5 JOINN
- 6.5.1 JOINN Company Information
- 6.5.2 JOINN Business Overview
- 6.5.3 JOINN Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 JOINN Genetically Modified Animal Models Product Portfolio
- 6.5.5 JOINN Recent Developments
- 6.6 China Environmental Technology and Bioenergy
- 6.6.1 China Environmental Technology and Bioenergy Company Information
- 6.6.2 China Environmental Technology and Bioenergy Business Overview
- 6.6.3 China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio
- 6.6.5 China Environmental Technology and Bioenergy Recent Developments
- 6.7 Charles River
- 6.7.1 Charles River Company Information
- 6.7.2 Charles River Business Overview
- 6.7.3 Charles River Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Charles River Genetically Modified Animal Models Product Portfolio
- 6.7.5 Charles River Recent Developments
- 6.8 Taconic Biosciences
- 6.8.1 Taconic Biosciences Company Information
- 6.8.2 Taconic Biosciences Business Overview
- 6.8.3 Taconic Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Taconic Biosciences Genetically Modified Animal Models Product Portfolio
- 6.8.5 Taconic Biosciences Recent Developments
- 6.9 GenOway
- 6.9.1 GenOway Company Information
- 6.9.2 GenOway Business Overview
- 6.9.3 GenOway Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 GenOway Genetically Modified Animal Models Product Portfolio
- 6.9.5 GenOway Recent Developments
- 6.10 CLEA Japan
- 6.10.1 CLEA Japan Company Information
- 6.10.2 CLEA Japan Business Overview
- 6.10.3 CLEA Japan Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CLEA Japan Genetically Modified Animal Models Product Portfolio
- 6.10.5 CLEA Japan Recent Developments
- 6.11 Ozgene
- 6.11.1 Ozgene Company Information
- 6.11.2 Ozgene Business Overview
- 6.11.3 Ozgene Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Ozgene Genetically Modified Animal Models Product Portfolio
- 6.11.5 Ozgene Recent Developments
- 6.12 InVivo Biosystems
- 6.12.1 InVivo Biosystems Company Information
- 6.12.2 InVivo Biosystems Business Overview
- 6.12.3 InVivo Biosystems Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 InVivo Biosystems Genetically Modified Animal Models Product Portfolio
- 6.12.5 InVivo Biosystems Recent Developments
- 6.13 Harbour BioMed
- 6.13.1 Harbour BioMed Company Information
- 6.13.2 Harbour BioMed Business Overview
- 6.13.3 Harbour BioMed Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Harbour BioMed Genetically Modified Animal Models Product Portfolio
- 6.13.5 Harbour BioMed Recent Developments
- 6.14 PolyGene
- 6.14.1 PolyGene Company Information
- 6.14.2 PolyGene Business Overview
- 6.14.3 PolyGene Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 PolyGene Genetically Modified Animal Models Product Portfolio
- 6.14.5 PolyGene Recent Developments
7 North America
- 7.1 North America Genetically Modified Animal Models Market Size (2021-2032)
- 7.2 North America Genetically Modified Animal Models Market Size by Type
- 7.2.1 North America Genetically Modified Animal Models Market Size by Type (2021-2026)
- 7.2.2 North America Genetically Modified Animal Models Market Size by Type (2027-2032)
- 7.2.3 North America Genetically Modified Animal Models Market Share by Type (2021-2032)
- 7.3 North America Genetically Modified Animal Models Market Size by Application
- 7.3.1 North America Genetically Modified Animal Models Market Size by Application (2021-2026)
- 7.3.2 North America Genetically Modified Animal Models Market Size by Application (2027-2032)
- 7.3.3 North America Genetically Modified Animal Models Market Share by Application (2021-2032)
- 7.4 North America Genetically Modified Animal Models Market Size by Country
- 7.4.1 North America Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Genetically Modified Animal Models Market Size by Country (2021-2026)
- 7.4.3 North America Genetically Modified Animal Models Market Size by Country (2027-2032)
- 7.4.4 North America Genetically Modified Animal Models Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Genetically Modified Animal Models Market Size (2021-2032)
- 8.2 Europe Genetically Modified Animal Models Market Size by Type
- 8.2.1 Europe Genetically Modified Animal Models Market Size by Type (2021-2026)
- 8.2.2 Europe Genetically Modified Animal Models Market Size by Type (2027-2032)
- 8.2.3 Europe Genetically Modified Animal Models Market Share by Type (2021-2032)
- 8.3 Europe Genetically Modified Animal Models Market Size by Application
- 8.3.1 Europe Genetically Modified Animal Models Market Size by Application (2021-2026)
- 8.3.2 Europe Genetically Modified Animal Models Market Size by Application (2027-2032)
- 8.3.3 Europe Genetically Modified Animal Models Market Share by Application (2021-2032)
- 8.4 Europe Genetically Modified Animal Models Market Size by Country
- 8.4.1 Europe Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Genetically Modified Animal Models Market Size by Country (2021-2026)
- 8.4.3 Europe Genetically Modified Animal Models Market Size by Country (2027-2032)
- 8.4.4 Europe Genetically Modified Animal Models Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Genetically Modified Animal Models Market Size (2021-2032)
- 9.2 China Genetically Modified Animal Models Market Size by Type
- 9.2.1 China Genetically Modified Animal Models Market Size by Type (2021-2026)
- 9.2.2 China Genetically Modified Animal Models Market Size by Type (2027-2032)
- 9.2.3 China Genetically Modified Animal Models Market Share by Type (2021-2032)
- 9.3 China Genetically Modified Animal Models Market Size by Application
- 9.3.1 China Genetically Modified Animal Models Market Size by Application (2021-2026)
- 9.3.2 China Genetically Modified Animal Models Market Size by Application (2027-2032)
- 9.3.3 China Genetically Modified Animal Models Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Genetically Modified Animal Models Market Size (2021-2032)
- 10.2 Asia Genetically Modified Animal Models Market Size by Type
- 10.2.1 Asia Genetically Modified Animal Models Market Size by Type (2021-2026)
- 10.2.2 Asia Genetically Modified Animal Models Market Size by Type (2027-2032)
- 10.2.3 Asia Genetically Modified Animal Models Market Share by Type (2021-2032)
- 10.3 Asia Genetically Modified Animal Models Market Size by Application
- 10.3.1 Asia Genetically Modified Animal Models Market Size by Application (2021-2026)
- 10.3.2 Asia Genetically Modified Animal Models Market Size by Application (2027-2032)
- 10.3.3 Asia Genetically Modified Animal Models Market Share by Application (2021-2032)
- 10.4 Asia Genetically Modified Animal Models Market Size by Country
- 10.4.1 Asia Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Genetically Modified Animal Models Market Size by Country (2021-2026)
- 10.4.3 Asia Genetically Modified Animal Models Market Size by Country (2027-2032)
- 10.4.4 Asia Genetically Modified Animal Models Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type
- 11.2.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Genetically Modified Animal Models Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application
- 11.3.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Genetically Modified Animal Models Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country
- 11.4.1 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Genetically Modified Animal Models Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Genetically Modified Animal Models Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst